CLINICAL STUDIES
Laser angioplasty of restenosed coronary stents: results of a multicenter surveillance trial
Ralf Köster, MD1,
Christian W. Hamm, MD, FACC1,
Ricardo Seabra-Gomes, MD, FACC2,
Gunhild Herrmann, MD3,
Horst Sievert, MD4,
Carlos Macaya, MD5,
Eckart Fleck, MD6,
Klaus Fischer, MD7,
Johannes J. R. M. Bonnier, MD, PhD8,
Jean Fajadet, MD9,
J.ürgen Waigand, MD10,
Karl-Heinz Kuck, MD, FACC11,
Michel Henry, MD12,
Marie Claude Morice, MD13,
Luciano Pizzulli, MD14,
Michael M. Webb-Peploe, MD15,
Arnd B. Buchwald, MD16,
Lars Ekström, MD17,
Eberhard Grube, MD18,
Saad Al Kasab, MD, FACC19,
Antonio Colombo, MD, FACC20,
Archimedes Sanati, MD21,
Sjef M. P. G. Ernst, MD22,
Michael Haude, MD23,
Martin B. Leon, MD, FACC24,
Charles Ilsley, MD25,
Rafael Beyar, MD, FACC26,
Yvo Taeymans, MD27,
Uwe Gladbach28,
Karl Wegscheider, PhD29,
Patrick W. Serruys, MD, PhD, FACC30 for the Laser Angioplasty of Restenosed Stents (LARS) Investigators
1 Medical Clinic, Department of Cardiology, University Hospital Eppendorf, Hamburg, Germany
2 Hospital Santa Cruz, Lisbon, Portugal
3 Department of Medicine, Christian-Albrechts University, Kiel, Germany
4 Cardiovascular Center Bethanien, Frankfurt, Germany
5 University Hospital San Carlos, Madrid, Spain
6 German Heart Institute, Berlin, Germany
7 Clementinen Hospital, Hannover, Germany
8 Catharina Hospital, Eindhoven, The Netherlands
9 Clinique Pasteur, Toulouse, France
j 10Humboldt-University Berlin, Franz Volhard Clinic, Berlin, Germany
k 11St. George Hospital, Hamburg, Germany
l 12Clinique de Essey, Nancy, France
m 13Clinique du Bois de Verrieres, Antony, France
n 14University Hospital, University of Bonn, Bonn, Germany
o 15St. Thomas Hospital, London University, London, England, United Kingdom
p 16University Clinic, Göttingen, Germany
q 17Sahlgrenska University Hospital, Gotenburg, Sweden
r 18Siegburg Hospital, Siegburg, Germany
s 19Prince Sultan Cardiac Center, Riyadh, Saudi Arabia
t 20Centro Cuore Columbus, Milan, Italy
u 21Sharyati Hospital, Tehran, Iran
v 22Antonius Hospital, Nieuwegein, The Netherlands
w 23University Hospital, Essen, Germany
x 24Washington Hospital Center, Washington, D.C., USA
y 25Harefield Hospital, Harefield, England, United Kingdom
z 26Rambam Medical Center, Haifa, Israel
* 27University Hospital Ghent, Ghent, Belgium
28Spectranetics, Inc., Nieuwegein, The Netherlands
29Wegscheider Biometry and Statistics, Inc., Berlin, Germany
¶ 30University Hospital Dijkzigt, Thoraxcenter, Erasmus University, Rotterdam, The Netherlands
Reprint requests and correspondence: C.W. Hamm, MD, Kerckhoff Heart Center, Dept. of Cardiology, Benekestr. 2-8, 61231 Bad Nauheim, Germany christian.hamm{at}kerckhoff.med.uni-giessen.de
OBJECTIVES
This study evaluated safety and efficacy of excimer laser angioplasty for treatment of restenosed or occluded coronary stents.
BACKGROUND
Balloon angioplasty of in-stent restenosis is limited by a high recurrence rate. Debulking by laser angioplasty is a novel concept to treat in-stent restenosis.
METHODS
A total of 440 patients with restenoses or occlusions in 527 stents were enrolled for treatment with concentric or eccentric laser catheters and adjunctive balloon angioplasty.
RESULTS
Laser angioplasty success ( 50% diameter stenosis after laser treatment or successful passage with a 2.0-mm or 1.7-mm eccentric laser catheter) was achieved in 92% of patients. Adjunctive balloon angioplasty was performed in 99%. Procedural success (laser angioplasty success followed by 30% stenosis with or without balloon angioplasty) was 91%. There was neither a significant difference in success with respect to lesion length, nor were there differences between small and large vessels or native vessels and vein grafts. Success was higher and residual stenosis lower using large or eccentric catheters. Serious adverse events included death (1.6%, not directly laser catheter related), Q-wave myocardial infarction (0.5%), nonQ-wave infarction (2.7%), cardiac tamponade (0.5%) and stent damage (0.5%). Perforations after laser treatment occurred in 0.9% of patients and after balloon angioplasty in 0.2%. Dissections were visible in 4.8% of patients after laser treatment and in 9.3% after balloon angioplasty. Reinterventions during hospitalization were necessary in 0.9% of patients; bypass surgery was performed in 0.2%.
CONCLUSIONS
Excimer laser angioplasty with adjunctive balloon angioplasty is a safe and efficient technology to treat in-stent restenoses. These data justify a randomized comparison with balloon angioplasty.
|
Abbreviations and Acronyms
| | ACT | = activated clotting time | | CK | = creatine kinase | | PTCA | = percutaneous transluminal coronary angioplasty |
|
This article has been cited by other articles:

|
 |

|
 |
 
P. O'Kane and S. Redwood
Chapter 34 Laser
Oxford Textbook of Interventional Cardiology,
January 1, 2010;
1(1):
med-9780199569083-chapter - med-9780199569083-chapter.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. vom Dahl, U. Dietz, P. K. Haager, S. Silber, L. Niccoli, H. J. Buettner, F. Schiele, M. Thomas, P. Commeau, D. R. Ramsdale, et al.
Rotational Atherectomy Does Not Reduce Recurrent In-Stent Restenosis: Results of the Angioplasty Versus Rotational Atherectomy for Treatment of Diffuse In-Stent Restenosis Trial (ARTIST)
Circulation,
February 5, 2002;
105(5):
583 - 588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hoffmann and G.S. Mintz
Coronary in-stent restenosis--predictors, treatment and prevention
Eur. Heart J.,
November 1, 2000;
21(21):
1739 - 1749.
[PDF]
|
 |
|

|
 |

|
 |
 
J. Al Suwaidi, P. B. Berger, and D. R. Holmes Jr
Coronary Artery Stents
JAMA,
October 11, 2000;
284(14):
1828 - 1836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Koster, J. Kahler, W. Terres, J. Reimers, S. Baldus, D. Hartig, J.u. Berger, T. Meinertz, and C. W. Hamm
Six-month clinical and angiographic outcome after successful excimer laser angioplasty for in-stent restenosis
J. Am. Coll. Cardiol.,
July 1, 2000;
36(1):
69 - 74.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Di Mario and E. Karvouni
The bigger, the better: true also for in-stent restenosis?
Eur. Heart J.,
May 1, 2000;
21(9):
710 - 711.
[PDF]
|
 |
|
|